Clinical Trials Directory

Trials / Completed

CompletedNCT06004583

C-Reactive Protein/Albumin Ratio and Acne Vulgaris

Relationships Between Disease Severity and The C-Reactive Protein/Albumin Ratio and Various Hematological Parameters in Patients With Acne Vulgaris

Status
Completed
Phase
Study type
Observational
Enrollment
96 (actual)
Sponsor
Ataturk University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Objective: Acne vulgaris, an inflammatory disease, was investigated in this study with the claim that C-reactive protein (CRP) / albumin ratio and some hematological parameter ratios have the potential to be used as inflammatory markers to monitor disease severity and prognosis. Methods: A descriptive cross-sectional study was conducted with two groups of patients aged 18-65 years, 61 patients diagnosed with acne vulgaris and 35 healthy control patients, and routine hemogram and biochemical parameters were compared. The Global Acne Severity Index was used to determine the severity of acne vulgaris.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBiochemical blood analysisSerum CRP and albumin levels

Timeline

Start date
2022-01-05
Primary completion
2023-02-02
Completion
2023-05-01
First posted
2023-08-22
Last updated
2023-08-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06004583. Inclusion in this directory is not an endorsement.

C-Reactive Protein/Albumin Ratio and Acne Vulgaris (NCT06004583) · Clinical Trials Directory